CCND1 and ovarian cancer: In this study, Western blot analysis demonstrated a dose-dependent reduction of cyclin D1 in human ovarian cancer cell lines, but not in non-cancerous IOSE cell cultures or in cervical tissues from individual animals treated for 6 weeks with the diet containing various SHetA2 doses (Fig. 7).